Category: japan retractions

Déjà vu: Double pub in the same issue earns a retraction

biomedchromAlways do a careful reading of your galleys, editors.

We imagine readers of Biomedical Chromatography’s special issue, “Reminiscences of Chang Kee Lim,” did some flipping back and forth when they found the same paper published twice.

Here’s the resulting notice for “Determination of 4-hydroxy-2-nonenal in serum by high-performance liquid chromatography with fluorescence detection after pre-column derivatization using 4-(N,N-dimethylaminosulfonyl)-7-hydrazino-2,1,3-benzoxadiazole”:  Continue reading Déjà vu: Double pub in the same issue earns a retraction

Researcher with 25 retractions covered up other fraud, says university

Shigeaki Kato
Shigeaki Kato

The Japanese endocrinology researcher Shigeaki Kato, with at least 25 retractions to his name, is alleged to have been the ringleader of a scheme to cover up other research misconduct at the University of Tokyo, his former employer, which investigated the activity.

According to the Japan Times, Kato and three other colleagues took steps to hide evidence of image manipulation in five of 51 theses between 1996 and 2011: Continue reading Researcher with 25 retractions covered up other fraud, says university

STAP stem cell co-author commits suicide: Reports

Yoshiki Sasai, via RIKEN
Yoshiki Sasai, via RIKEN

In a stunning and tragic development, a co-author of the now-retracted Nature papers claiming to have found an easy way to create stem cells has committed suicide, according to news reports in Japan.

According to the Japan Times, RIKEN deputy director Yoshiki Sasai has died: Continue reading STAP stem cell co-author commits suicide: Reports

UT-Southwestern cancer research group notches ninth retraction

lung cancerA research team at the University of Texas-Southwestern that has retracted eight papers for image manipulation has retracted another, this one in Lung Cancer.

Here’s the notice for “Aberrant methylation of Reprimo in lung cancer,” published by Adi Gazdar’s group: Continue reading UT-Southwestern cancer research group notches ninth retraction

Paper about widely touted but unapproved “cure” for cancer, autism retracted

int j cancerA paper about a protein being used — unapproved by health agencies — to treat diseases including cancer and autism has been retracted.

Here’s the notice from the International Journal of Cancer about a 2007 paper purporting to show that the substance, GcMAF, is useful against breast cancer: Continue reading Paper about widely touted but unapproved “cure” for cancer, autism retracted

Publishing gadfly demands journal editor’s resignation, then has “fairly incomprehensible” paper rejected

sci eng ethicsA scientific publishing gadfly who was banned earlier this year from an Elsevier journal for “personal attacks and threats” has had a paper rejected by a Springer journal after he called for the editor’s resignation because of alleged incompetence.

As detailed in a comment left at Retraction Watch, Jaime A. Teixeira da Silva submitted a manuscript titled “One Conjunction, a World of Ethical Difference: How Elsevier, the ICMJE and Neurology Define Authorship” to Science and Engineering Ethics on November 11, 2012. As of last week, despite a number of messages sent to editors of the journal, he had not had a decision on the manuscript.

As a result, on July 14 of this year, Teixeira da Silva sent this letter to journal editor Raymond Spier and to Stephanie Bird, an editorial board member assigned to the manuscript: Continue reading Publishing gadfly demands journal editor’s resignation, then has “fairly incomprehensible” paper rejected

STAP stem cell papers officially retracted as Nature argues peer review couldn’t have detected fatal problems

nature 714A significant chapter of the nearly six-month saga of the STAP stem cell controversy has come to an end, with Nature running retraction notices for the two papers involved. The journal has also published an editorial about the case that’s worth a read.

The retractions for “Bidirectional developmental potential in reprogrammed cells with acquired pluripotency” and “Stimulus-triggered fate conversion of somatic cells into pluripotency” both read: Continue reading STAP stem cell papers officially retracted as Nature argues peer review couldn’t have detected fatal problems

RIKEN inquiry prompted by STAP stem cell controversy generates three corrections

rikenlogo_enA review of past publications by the Japanese research institution RIKEN has produced three corrections of articles by a molecular geneticist, Haruhiko Koseki, The Scientist is reporting. The articles had appeared in Molecular and Cellular Biology between 2005 and 2010.

The review was triggered by the scandal involving Haruko Obokata, a former RIKEN scientist whose work on STAP stem cells has come under scrutiny. However, RIKEN officials said the corrections are unrelated to the Obokata case. Obokata has reportedly agreed to retract two of her articles in Nature. (RIKEN has released an English-language translation of its response to Obokata’s appeal against charges of research misconduct.)

According to The Scientist, Koseki was a member of a committee charged with investigating Obokata’s STAP results: Continue reading RIKEN inquiry prompted by STAP stem cell controversy generates three corrections

UT-Southwestern cancer researchers up to 8 retractions

oncogeneA group at the University of Texas Southwestern led by Adi F. Gazdar that found evidence of inappropriate image manipulation in a number of their papers has retracted its seventh and eighth studies.

Here’s the notice for 2005’s “Aberrant methylation profile of human malignant mesotheliomas and its relationship to SV40 infection,” in Oncogene: Continue reading UT-Southwestern cancer researchers up to 8 retractions

Obokata agrees to retract one of two STAP stem cell papers in Nature: Reports

nature 2-27-14The Kyodo News service has reported that Haruko Obokata has agreed to retract one of the two Nature papers on an easy method of making stem cells.

According to the report: Continue reading Obokata agrees to retract one of two STAP stem cell papers in Nature: Reports